Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05104359 · ClinicalTrials.gov registry record

COVID-19 Quantitative Antibody Titers & Booster Vaccinations

A clinical trial of COVID-19 and COVID-19 Vaccines, sponsored by Epividian.

Completed
Registry status
825
Enrollment target
1
Study location

NCT05104359 is a study of COVID-19 and COVID-19 Vaccines that has completed, run by Epividian. The registered enrollment target is 825 participants, below the 55,210-participant average among 203 other COVID-19 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05104359, a study of COVID-19 and COVID-19 Vaccines, has completed, sponsored by Epividian.

COMPLETED
Registry status
825 participants
Enrollment target
1
Study location

Study Summary

This is an observational study aiming at describing COVID-19 vaccination outcomes among HIV-positive and HIV-negative individuals, using electronic health records to observe their usual clinical care. This study will describe levels of COVID-19 vaccine response (i.e., Ig spike antibody measurements). Rates of antibody level decay after vaccination will be assessed. The efficacy of using antibody levels to help guide the timing of booster doses among HIV-negative and HIV-positive patients will be evaluated.

Conditions Studied

COVID-19 COVID-19 Vaccines Immunogenicity, Vaccine

Interventions

  • OTHER Observational

Study Locations (1)

New York

  • AHD Manhattan Midtown HCC - New York

Trial Details

FieldValue
Enrollment Target 825 participants
Start Date 2020-12-11
Est. Completion 2022-04-30

Sponsor

Epividian

8 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05104359

The ClinicalTrials.gov registry entry for NCT05104359 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 825 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,210-participant average among 203 other COVID-19 trials with a reported enrollment target (99% lower). The listed sponsor is Epividian, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which Observational is the first listed.

NCT05104359 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05104359 about?

NCT05104359 is a clinical study titled "COVID-19 Quantitative Antibody Titers & Booster Vaccinations". This is an observational study aiming at describing COVID-19 vaccination outcomes among HIV-positive and HIV-negative individuals, using electronic health records to observe their usual clinical care. This study will describe levels of COVID-19 vaccine response (i.e., Ig spike antibody measurements)...

What is the current status of trial NCT05104359?

This trial is currently completed. The enrollment target is 825 participants. The study started on 2020-12-11. Estimated completion is 2022-04-30.

What conditions does trial NCT05104359 study?

This clinical trial studies the following conditions: COVID-19, COVID-19 Vaccines, Immunogenicity, Vaccine.

What interventions are being tested in trial NCT05104359?

The interventions under investigation include: Observational (OTHER).

Who is sponsoring clinical trial NCT05104359?

This trial is sponsored by Epividian, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05104359 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

COVID-19

All registered trials for this condition

COVID-19 Vaccines

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.